Stock kasuwa, musayar ciniki a yau
Rahoton samfurori na kamfanonin 71229 a ainihin lokacin.
Stock kasuwa, musayar ciniki a yau

Rahoton samfurori

Stock ya faɗi a kan layi

Stock ya faɗi tarihi

Kasashen kasuwancin jari

Stock dividends

Riba daga kamfanin kamfanoni

Rahotan kuɗi

Ƙididdiga na kamfanoni. A ina zan zuba kudi?

Kala Pharmaceuticals, Inc. kasuwar kasuwa

Matsayin kasuwancin jari na Kala Pharmaceuticals, Inc. a yau da kuma tarihin ƙaddamar da Kala Pharmaceuticals, Inc. daga farkon kasuwanci a KALA hannun jari akan musayar jari.
Ƙara zuwa widget din
Ƙara zuwa widget din

Kala Pharmaceuticals, Inc. girma

Yau kasuwa kasuwa na Kala Pharmaceuticals, Inc. shine 30 888 876 US dollar.
-486 118 $ (-1.55%)
canji na strongn kudi tun jiya

Kala Pharmaceuticals, Inc. capitalization akan layi yau akan dala. Kala Pharmaceuticals, Inc. capitalization a yau ana ɗaukar su a matsayin jimlar duk abin da aka ambata Kala Pharmaceuticals, Inc.. Wannan shi ne bayanin tunani game da Kala Pharmaceuticals, Inc. capitalization. Kala Pharmaceuticals, Inc., ikon mallaka - 30 888 876 dalar Amurka.

Kala Pharmaceuticals, Inc. girma na kasuwanci

Yau yaudarar kasuwancin jari Kala Pharmaceuticals, Inc. ya kai 10 181 US dollar.
-37 768 $ (-78.77%)
canjin karuwar kasuwancin tun jiya

Kala Pharmaceuticals, Inc. kundin ciniki na yau = = 10 181 dalar Amurka. Kala Pharmaceuticals, Inc. ginshiƙi na kasuwanci yana kan shafin yanar gizon mu kowace rana. Kala Pharmaceuticals, Inc. Ana gudanar da kasuwancin kan layi akan kasuwannin hannayen jari da yawa, muna nuna jimlar Kala Pharmaceuticals, Inc. ciniki a kowace rana. Kala Pharmaceuticals, Inc. aikin kwace filaye a kowace rana cikin dalar Amurka.

Nuna:
To

Kala Pharmaceuticals, Inc. kasuwar kasuwa

Kala Pharmaceuticals, Inc. aikin kwalliya akan zane a shekaru. Canjin Kala Pharmaceuticals, Inc. ikon mallaka a mako guda shine 2.28%. 0% a kowace shekara - wani canji a cikin kasuwar kasuwancin Kala Pharmaceuticals, Inc.. Babban ikon kasuwar Kala Pharmaceuticals, Inc. yanzu ya yi daidai da 30 888 876 dalar Amurka.

Week Watan 3 months Shekara 3 shekaru

Kala Pharmaceuticals, Inc. tarihin lalata

Kwanan Girma
Babban jari (kasuwannin kasuwa) shine kasuwa na kasuwa na kamfanonin da ke sayarwa akan musayar jari. Mahimmancin kasuwancin yana daidai da farashin hannun jari da yawa ta hanyar yawan kuɗi.
04/05/2023 30 888 876 $
03/05/2023 31 374 994 $
02/05/2023 30 179 950 $
01/05/2023 31 111 680 $
28/04/2023 31 192 700 $
27/04/2023 29 440 642 $
26/04/2023 30 200 204 $

Kala Pharmaceuticals, Inc. tashar girma

Week Watan 3 months Shekara 3 shekaru

Kala Pharmaceuticals, Inc. bayanan tarihi na tarihi

Kwanan Volume (24h)
Ƙaramar kasuwancin Kala Pharmaceuticals, Inc. hannun jari shine yawan yawan ma'amaloli tare da hannun jari na KALA da aka saya a lokacin da aka zaba.
04/05/2023 10 181 $
03/05/2023 47 949 $
02/05/2023 7 155 $
01/05/2023 107 843 $
28/04/2023 334 611 $
27/04/2023 7 016 $
26/04/2023 30 557 $

Kala Pharmaceuticals, Inc. capitalization daidai yake da 30 888 876 Dalar Amurka a 04/05/2023. Kala Pharmaceuticals, Inc. karuwancin kasuwa a 03/05/2023 yayi daidai da 31 374 994 dalar Amurka. Kala Pharmaceuticals, Inc. karfaffen kaya ya kasance zuwa 30 179 950 Dalar Amurka a 02/05/2023. 01/05/2023 Kala Pharmaceuticals, Inc. ikon mallaka daidai yake da 31 111 680 dalar Amurka.

Kasuwancin kasuwa na Kala Pharmaceuticals, Inc. wanda aka ƙira zuwa 31 192 700 Dalar Amurka a 28/04/2023. Babban tsarin kasuwancin Kala Pharmaceuticals, Inc. a 27/04/2023 wanda aka kimanta zuwa 29 440 642 dalar Amurka. Kala Pharmaceuticals, Inc. aikin mallaka a 26/04/2023 yayi daidai da 30 200 204 dalar Amurka.

A capitalization na Kala Pharmaceuticals, Inc. a yau shi ne 30 888 876 $. Girman kasuwa na Kala Pharmaceuticals, Inc. ya canza zuwa -1.549% idan aka kwatanta da jiya. Hanyoyin ciniki na KALA hannun jari na Kala Pharmaceuticals, Inc. a rana ta ƙarshe ta kasuwanci ya kasance 10 181 $. Ƙarin ciniki na Kala Pharmaceuticals, Inc. ya canza zuwa -78.767% idan aka kwatanta da ranar ciniki.

Kudin hannun jari Kala Pharmaceuticals, Inc.

Finance Kala Pharmaceuticals, Inc.